Ignite Creation Date:
2024-05-06 @ 9:28 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02994290
Status:
COMPLETED
Last Update Posted:
2023-01-09
First Post:
2016-12-08
Brief Title:
Evaluation of the Implementation and Effectiveness of IPP-HPV
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Evaluation of the Implementation and Effectiveness of a Pilot Quality Improvement Program to Increase HPV Vaccine Uptake Inpatient Postpartum HPV Immunization IPP-HPV Program
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the proposed pilot study is to assess the implementation of IPP-HPV immunization at Yale New Haven Hospital YNHH and to identify potential barriers to and facilitators of this intervention to optimize its feasibility and effectiveness It is imperative that innovative interventions be developed to achieve comprehensive utilization of this highly effective vaccine to reduce rates of HPV infection lower rates of cervical and other HPV associated cancers and address cancer disparities
Detailed Description:
Administration of the HPV vaccine during the inpatient postpartum hospital stay has the potential to be an innovative intervention to improve HPV immunization rates Following onset of pregnancy the postpartum period becomes the next available opportunity to immunize with the HPV vaccine which is safe in breastfeeding women The benefits of such an intervention include a focus on women engaged with the health care system who are often highly motivated to invest in their personal health
Specific Aims Aim 1 To evaluate receptivity and concerns of postpartum women with receiving the HPV vaccine during the inpatient postpartum admission as part of the Inpatient Postpartum HPV Immunization Quality Improvement Program IPP-HPV
Aim 2 To evaluate receptivity and concerns of healthcare providers with inpatient postpartum HPV immunization as part of IPP-HPV and to identify facilitators of and barriers to its implementation
Aim 3 To assess the uptake and effectiveness of a Pilot Quality Improvement Program to increase HPV vaccine uptake IPP-HPV for Yale New Haven Hospital YNHH Womens Center and Center for Womens Health and Midwifery CWHM postpartum patients 26 years of age who deliver at YNHH York Street Campus YSC or Saint Raphael Campus SRC
Specific Aims Aim 1 To evaluate receptivity and concerns of postpartum women with receiving the HPV vaccine during the inpatient postpartum admission as part of the Inpatient Postpartum HPV Immunization Quality Improvement Program IPP-HPV
Aim 2 To evaluate receptivity and concerns of healthcare providers with inpatient postpartum HPV immunization as part of IPP-HPV and to identify facilitators of and barriers to its implementation
Aim 3 To assess the uptake and effectiveness of a Pilot Quality Improvement Program to increase HPV vaccine uptake IPP-HPV for Yale New Haven Hospital YNHH Womens Center and Center for Womens Health and Midwifery CWHM postpartum patients 26 years of age who deliver at YNHH York Street Campus YSC or Saint Raphael Campus SRC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1K07CA230234-01 | NIH | None | httpsreporternihgovquickSearch1K07CA230234-01 |